QIAGEN Aktie
37,34EUR | 0,65EUR | 1,76% |
WKN DE: A40ZZU / ISIN: NL0015002CX3
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 5 610 | 6 028 | 6 178 | 5 967 | 0 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,33 | 0,37 | 0,35 | 0,33 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 667 | 2 110 | 2 394 | 2 148 | 1 960 |
Summe Anlagevermögen | 4 245 | 4 037 | 3 894 | 3 968 | 3 730 |
Summe Aktiva | 5 913 | 6 147 | 6 288 | 6 115 | 5 690 |
Bilanz (in Mio. USD) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 3 115 | 3 050 | 2 821 | 2 307 | 2 122 |
Summe Eigenkapital | 2 798 | 3 097 | 3 467 | 3 808 | 3 567 |
Summe Passiva | 5 913 | 6 147 | 6 288 | 6 115 | 5 690 |
Adresse
Hulsterweg 82, 5912 PL Venlo | |
Telefon | +31 (77) 355-66-00 |
Internet | http://www.qiagen.com |
Management
Antonio Santos
Senior Vice President & Head-Global Operations |
Bert van Meurs
Member-Supervisory Board |
Elaine R. Mardis
Member-Supervisory Board |
Elizabeth E. Tallett
Member-Supervisory Board |
Eva Pisa
Member-Supervisory Board |
Eva van Pelt
Member-Supervisory Board |
Jean-Pascal Viola
SVP, Head-Strategy & Business Development |
John Gilardi
Head-Investor Relations & Corporate Communications |
Jonathan G. Sheldon
Senior VP-Digital Insights Business Area |
Lawrence A. Rosen
Chairman-Supervisory Board |
Lezette Young
Manager-Global Compliance |
Metin Colpan
Member-Supervisory Board |
Nedal Safwat
VP & Head-Molecular Diagnostics North America |
Philipp von Hugo
VP, Head-Global Legal Affairs & Compliance |
Roland Sackers
Chief Financial Officer & Managing Director |
Ross L. Levine
Member-Supervisory Board |
Stephany Foster
Senior Vice President & Head-Human Resources |
Stephen H. Rusckowski
Member-Supervisory Board |
Thierry Bernard
Chief Executive Officer & Managing Director |
Thomas Theuringer
Senior Director-Corporate Communications |
Toralf Haag
Member-Supervisory Board |